EC Number   |
Application |
Reference |
|---|
   2.7.7.49 | analysis |
the laser capture microdissection microscopycombined with multiplex quantitative real-time reverse transcriptase PCR, LCMM/qRTPCR, technique can be used to resolve and quantify GFP mRNA variability at high spatial resolution, the method is useful for quantification of any gene expressed by bacteria in their native environment, method development, overview |
690537 |
| 2.7.7.49 | drug development |
characterization, and lead optimization of 7-azaindole non-nucleoside HIV-1 reverse transcriptase inhibitors |
760694 |
| 2.7.7.49 | drug development |
HIV-1 reverse transcriptase is a major target of antiviral therapy |
-, 723753 |
| 2.7.7.49 | drug development |
modeling the functional state of the reverse transcriptase of hepatitis B virus and its application to probing drug-protein interaction |
760782 |
| 2.7.7.49 | drug development |
the enzyme is a drug target |
714972 |
| 2.7.7.49 | drug development |
the enzyme is a primary target in the development of antiviral agents against HIV-1 |
716827 |
| 2.7.7.49 | medicine |
combination therapy consisting of nucleoside reverse-transcriptase together with non-nucleoside reverse-transcriptase inhibitors or protease inhibitors leads to a suppression of viral replication |
692252 |
| 2.7.7.49 | medicine |
gene inhibition causing reduction of telomerase reverse transcriptase activity may provide a basis for cancer therapeutics |
691882 |
| 2.7.7.49 | medicine |
HIV-1 reverse transcriptase is a major target of antiviral therapy |
-, 723753 |
| 2.7.7.49 | medicine |
target in HIV therapy |
692567 |
